RxDoctor Payments Data

Laura Given, MD

Family Medicine · Largo, FLNPI 1992230262

Payments from drug & device makers

$2,534in general payments, 2019–2025

Across 129 payments — averaging $19.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$468
  • AbbVie$391
  • AstraZeneca$278
  • Pfizer$246
  • Amgen$207
  • Dynavax Technologies Corporation$148
  • plus $797 from 15 others

What the payments were for

  • Food & beverage$2,534100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,534 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$25,635
Medicare patients
176
Services billed
382

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide56$106,135
EliquisApixaban79$80,765
JardianceEmpagliflozin49$71,854
TrulicityDulaglutide41$63,255
FarxigaDapagliflozin Propanediol25$39,990
TradjentaLinagliptin29$32,660
XareltoRivaroxaban14$21,894
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$16,620
JanuviaSitagliptin Phosphate11$16,534
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$15,057
Lantus SolostarInsulin Glargine,hum.Rec.Anlog53$10,278
Albuterol Sulfate HfaAlbuterol Sulfate166$8,945
SymbicortBudesonide/Formoterol Fumarate17$7,897
MultaqDronedarone Hcl11$6,532
Diclofenac Sodium57$6,245

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$468$106,13556 claims
PfizerEliquis$246$80,76579 claims
Lilly USA, LLCTrulicity$142$63,25541 claims
AstraZenecaFarxiga, Symbicort$278$47,88742 claims
MerckJanuvia$42$16,53411 claims
GSKTrelegy Ellipta$31$15,05711 claims
AbbVieSynthroid$391$1,42413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Largo

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →